Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy

Indian Journal of Leprosy

Volumn 73, Issue 1, 2001, Pages 1-10

  Li, H Y ^a   Ran, S P ^a   Weng, X M ^a   Li, T G ^a   Deng, X H ^a   Li, F T ^a  

^a NONE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; HUMAN; LEPROSY; LONG TERM CARE; MAJOR CLINICAL STUDY; MONOTHERAPY; MYCOBACTERIUM LEPRAE; NONHUMAN; PREMEDICATION; RELAPSE;

ANIMALS; DAPSONE; DRUG THERAPY, COMBINATION; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MICE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM LEPRAE; RECURRENCE; RIFAMPIN;

EID: 0035044961     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Primary dapsone resistance in China
2. Application of polymerase chain reaction for the detection of Mycobacterium leprae in skin tissues
3. S-100 Protein and immuno peroxidase technique as an aid in the histopathologic diagnosis of leprosy
4. Recent developments in the field of multidrug therapy and future research in chemotherapy of leprosy
5. Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin
6. Secondary dapsone-resistant leprosy in Shanghai municipality
7. Problems of leprosy relapse in China
8. Long-term effect of leprosy control in two prefectures of China, 1995-1993
9. Risk of relapse in leprosy after fixed duration multidrug therapy
10. Enhancement in the histological diagnosis of indeterminate leprosy by demonstration of mycobacterial antigen
11. Immuno-histopathology in the diagnosis of early leprosy
12. Chemotherapy of leprosy for control programmes
13. THELEP controlled clinical trials in lepromatous leprosy
14. Seventh Report of Expert Committee on Leprosy